InvestSMART

Mach7 Technologies Limited (ASX: M7T) - Announcements

Current share price for M7T : $0.280 0.015 (5.08%)+

ASX company news and announcements for Mach7 Technologies Limited (M7T) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mach7 Technologies Limited (M7T) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mach7 Technologies Limited (M7T), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mach7 Technologies Limited (M7T)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$66 Trading Halt 14 Nov 2016 8:49AM $0.040 $0.280 risen by 600%
$66 Mach7 Awarded UK NHS Approved Supplier Status 9 Nov 2016 11:17AM $0.039 $0.280 risen by 617.95%
$66 Notice of Annual General Meeting/Proxy Form 7 Nov 2016 4:25PM $0.039 $0.280 risen by 617.95%
$66 Appendix 4G and Corporate Governance Statement 20 Oct 2016 9:56AM $0.045 $0.280 risen by 522.22%
$66 Annual Report to shareholders 20 Oct 2016 9:51AM $0.045 $0.280 risen by 522.22%
$66 Investor Presentation and Company Update 12 Oct 2016 11:31AM $0.050 $0.280 risen by 460%
$66 Appendix 4C - quarterly 12 Oct 2016 10:06AM $0.047 $0.280 risen by 495.74%
$66 Microsoft Partnership for Enterprise Imaging Cloud Solution 5 Oct 2016 11:31AM $0.049 $0.280 risen by 471.43%
$66 Letter to Shareholders 19 Sep 2016 9:51AM $0.040 $0.280 risen by 600%
$66 Change of Melbourne Registry Address Notification 9 Sep 2016 4:31PM $0.041 $0.280 risen by 582.93%
$66 Mach7 Technologies Completes Major Implementation in Qatar 6 Sep 2016 9:38AM $0.044 $0.280 risen by 536.36%
$66 Cleansing Notice 2 Sep 2016 5:14PM $0.039 $0.280 risen by 617.95%
$66 Appendix 3B 2 Sep 2016 5:14PM $0.039 $0.280 risen by 617.95%
$66 FY2016 Appendix 4E and Financial Report 1 Sep 2016 8:22AM $0.046 $0.280 risen by 508.70%
$66 M7T awarded 2nd US Patent for Mobile Device Image Capture 25 Aug 2016 9:28AM $0.041 $0.280 risen by 582.93%
$66 Mach7 Selected by Large US Healthcare Network 18 Aug 2016 11:41AM $0.038 $0.280 risen by 636.84%
$66 Appendix 3B - Exercise of Options 16 Aug 2016 9:28AM $0.039 $0.280 risen by 617.95%
$66 Mach7 Signs Distribution Agreement in United Kingdom 9 Aug 2016 9:04AM $0.036 $0.280 risen by 677.78%
$66 Mach7 Signs Distribution Agreement in Europe 4 Aug 2016 9:39AM $0.040 $0.280 risen by 600%
$66 Market Update 3 Aug 2016 9:14AM $0.038 $0.280 risen by 636.84%
$66 Mach7 Selected by Large U.S. University Medical Centre 2 Aug 2016 9:23AM $0.036 $0.280 risen by 677.78%
$66 Change of Director's Interest Notice 1 Aug 2016 1:59PM $0.034 $0.280 risen by 723.53%
$66 Appendix 3B - Exercise of Options 1 Aug 2016 1:59PM $0.034 $0.280 risen by 723.53%
$66 Appendix 4C - quarterly 29 Jul 2016 3:59PM $0.034 $0.280 risen by 723.53%
$66 Change of Director's Interest Notice 28 Jun 2016 6:58PM $0.037 $0.280 risen by 656.76%

751 - 775 of 799 results

Page 31 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.